307 related articles for article (PubMed ID: 8659335)
1. [Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports].
Pouya M; Opsomer RJ; Wese FX; Saleh M; Donnay M; Van Cangh PJ
Acta Urol Belg; 1996 Mar; 64(1):47-53. PubMed ID: 8659335
[TBL] [Abstract][Full Text] [Related]
2. Incrusted cystitis after intravesical mitomycin C treatment.
Llopis M; Moreno J; Botella R; Algado M
Acta Urol Belg; 1993 Sep; 61(3):21-3. PubMed ID: 8256682
[TBL] [Abstract][Full Text] [Related]
3. Intravesical mitomycin C for superficial transitional cell carcinoma.
Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493
[TBL] [Abstract][Full Text] [Related]
4. Bladder wall calcification after intravesical mitomycin C treatment of superficial bladder cancer.
Drago PC; Badalament RA; Lucas J; Drago JR
J Urol; 1989 Oct; 142(4):1071-2. PubMed ID: 2507794
[TBL] [Abstract][Full Text] [Related]
5. Bladder wall fibrosis following intravesical mitomycin treatment for superficial bladder cancer.
Katz G; Hackett RL; Wajsman Z
Urology; 1996 Jun; 47(6):928-9. PubMed ID: 8677595
[TBL] [Abstract][Full Text] [Related]
6. BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.
Debruyne FM; van der Meijden AP; Franssen MP
Prog Clin Biol Res; 1989; 303():435-46. PubMed ID: 2506556
[No Abstract] [Full Text] [Related]
7. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
van der Meijden AP; DeBruyne FM
Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary fibrosis following instillation of mitomycin C in the urinary bladder].
Neubauer H; Blech M; Wilhelms E; Crieé CP; Neuhaus KL; Truss F
Urologe A; 1987 Jan; 26(1):41-3. PubMed ID: 3107190
[TBL] [Abstract][Full Text] [Related]
9. Severely contracted bladder following intravesical mitomycin C therapy.
Wajsman Z; McGill W; Englander L; Huben RP; Pontes JE
J Urol; 1983 Aug; 130(2):340-1. PubMed ID: 6410085
[TBL] [Abstract][Full Text] [Related]
10. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
11. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
Kurth KH; Bouffioux C; Sylvester R; de Pauw M
Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
[No Abstract] [Full Text] [Related]
12. [Mitomycin C in the topical treatment of superficial neoplasms of the bladder].
Milani C; Bassi PF; Meneghini A; Giunta A; Tejerizo JC; dal Bianco M; Zattoni F; Garbeglio A
Arch Esp Urol; 1989 Oct; 42(8):761-7. PubMed ID: 2515812
[TBL] [Abstract][Full Text] [Related]
13. Necrosis of the glans penis: a rare complication of intravesical therapy with mitomycin c.
Neulander EZ; Lismer L; Kaneti J
J Urol; 2000 Oct; 164(4):1306. PubMed ID: 10992393
[No Abstract] [Full Text] [Related]
14. BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale and design of the trial of the Southeast Co-operative Urological Group, The Netherlands.
van der Meijden PM; Debruyne FM; Steerenberg PA; de Jong WH; Doesburg W
Prog Clin Biol Res; 1989; 310():285-98. PubMed ID: 2505272
[No Abstract] [Full Text] [Related]
15. Bladder perforation: a potential risk of early endovesical chemotherapy with mitomycin C.
Racioppi M; Porreca A; Foschi N; Delicato G; Destito A; D'Addessi A
Urol Int; 2005; 75(4):373-5. PubMed ID: 16327311
[TBL] [Abstract][Full Text] [Related]
16. Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.
Böhle A; Bock PR
Urology; 2004 Apr; 63(4):682-6; discussion 686-7. PubMed ID: 15072879
[TBL] [Abstract][Full Text] [Related]
17. Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma.
Kalsi J; Harland SJ; Feneley MR
Expert Opin Drug Deliv; 2008 Jan; 5(1):137-45. PubMed ID: 18095933
[TBL] [Abstract][Full Text] [Related]
18. Allergy to mitomycin C complicating topical administration for urothelial cancer.
Inglis JA; Tolley DA; Grigor KM
Br J Urol; 1987 Jun; 59(6):547-9. PubMed ID: 3120846
[TBL] [Abstract][Full Text] [Related]
19. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
20. [Intravesical instillation in the treatment of superficial tumors of the bladder].
Chopin DK
Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]